 |
|
Search Term:
GROSSMAN A.B. see all results for grossman
|
Grossman A.B.
|
|
Author
|
Abdominal Ganglioneuromas in Adults
|
|
Urologia Internationalis 2003, Vol. 71, No. 1
|
|
Author
|
Advances in the Management of Paediatric Cushing's Disease
|
|
Hormone Research 2008, Vol. 69, No. 6
|
|
Author
|
AIP, a Protein Mutated in Familial Acromegaly, Plays a Role in the Regulation of Cell Proliferation and Shows Cell-Type Specific Subcellular Localisation
|
|
Hormone Research 2009, Vol. 71, Suppl. 1
|
|
Author
|
Akting and Cycling: A Tale of the Pituitary
|
|
Hormone Research 2004, Vol. 62, Suppl. 3
|
|
Author
|
Cell Cycle Dysregulation in Pituitary Oncogenesis
|
|
Molecular Pathology of the Pituitary
|
|
Author
|
Cushing's Disease in Childhood: Presentation, Investigation, Treatment and Long-Term Outcome
|
|
Hormone Research 2001, Vol. 55, Suppl. 1
|
|
Author
|
Detection of Neuroendocrine Liver Metastases with MnDPDP-Enhanced MRI
|
|
Neuroendocrinology 2009, Vol. 89, No. 3
|
|
Author
|
Efficient Short-Term Control of Hypercortisolaemia by Low-Dose Etomidate in Severe Paediatric Cushing's Disease
|
|
Hormone Research 2005, Vol. 64, No. 3
|
|
Author
|
Endotoxin Induces Interleukin-1 and Nitric Oxide Synthase mRNA in Rat Hypothalamus and Pituitary
|
|
Neuroendocrinology 1998, Vol. 67, No. 1
|
|
Author
|
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Follow-Up and Documentation
|
|
Neuroendocrinology 2009, Vol. 90, No. 2
|
|
Author
|
Factors Influencing Skeletal Maturation at Diagnosis of Paediatric Cushing's Disease
|
|
Hormone Research 2007, Vol. 68, No. 5
|
|
Author
|
Growth Hormone Deficiency and Replacement in Patients with Treated Cushing's Disease, Prolactinomas and Non-Functioning Pituitary Adenomas: Effects on Body Composition, Glucose Metabolism, Lipid Status and Bone Mineral Density
|
|
Hormone Research 2006, Vol. 66, No. 6
|
|
Author
|
Growth in Disorders of Adrenal Hyperfunction
|
|
Hormone Research 2002, Vol. 58, Suppl. 1
|
|
Author
|
Medullary Thyroid Cancer: Molecular Biology and Novel Molecular Therapies
|
|
|
|
Author
|
Octreotide and the mTOR Inhibitor RAD001 (Everolimus) Block Proliferation and Interact with the Akt-mTOR-p70S6K Pathway in a Neuro-Endocrine Tumour Cell Line
|
|
Neuroendocrinology 2008, Vol. 87, No. 3
|
|
Author
|
Osteoporosis in Cushing´s Syndrome
|
|
Glucocorticoid-Induced Osteoporosis
|
|
Author
|
Prostaglandin E2 and Bacterial Lipopolysaccharide Stimulate Bioactive Interleukin-1 Release from Rat Hypothalamic Explants
|
|
Neuroendocrinology 1993, Vol. 57, No. 2
|
|
Author
|
Role of Fasting Plasma Glucose, Glycated Haemoglobin and Homeostatic Model Assessment in the Detection of Glucose Intolerance in Adult Hypopituitary Patients during Growth Hormone Replacement Therapy
|
|
Hormone Research 2008, Vol. 69, No. 2
|
|
Author
|
Role of Regulatory Factors in Pituitary Tumour Formation
|
|
Molecular Pathology of the Pituitary
|
|
Author
|
Targeted Radionuclide Therapy for Neuroendocrine Tumours: Principles and Application
|
|
|
|
Author
|
The Clinical Presentation (Symptoms and Signs) of Sporadic and Familial Chromaffin Cell Tumours (Phaeochromocytomas and Paragangliomas)
|
|
Pheochromocytoma
|
|
Author
|
The Discriminatory Value of the Low-Dose Dexamethasone Suppression Test in the Investigation of Paediatric Cushing's Syndrome
|
|
Hormone Research 2006, Vol. 65, No. 3
|
|
Author
|
The Heme Oxygenase-Carbon Monoxide Pathway in the Control of
Neuroendocrine Function
|
|
Neuroendocrine-Immune Interactions
|
|
Author
|
The Role of Carbon Monoxide in the Regulation of Neuroendocrine Function
|
|
Neuroimmunomodulation 1997, Vol. 4, No. 5-6
|